Related Experiment Video

Updated: Oct 10, 2025

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

27.3K

Pediatric Fecal Microbiota Transplantation in Recurrent Clostridioides Difficile

Jacob M Parnell, Maribeth R Nicholson, Richard Kellermayer

    Pediatric Annals
    |December 10, 2021
    PubMed

    Insights

    Fecal microbiota transplantation (FMT) is a key treatment for recurrent Clostridioides difficile infection (CDI) in children, addressing gut dysbiosis when antibiotics fail. This review covers FMT

    Area of Science:

    • Pediatric Gastroenterology
    • Microbiome Research
    • Infectious Diseases

    Background:

    • Rising incidence of Clostridioides difficile infection (CDI) in pediatric populations.
    • Limitations of standard antibiotic therapies for recurrent CDI (rCDI).
    • Gut dysbiosis as a central factor in rCDI pathogenesis.

    Purpose of the Study:

    • To review the indications for fecal microbiota transplantation (FMT) in pediatric rCDI.
    • To outline the procedures and safety considerations of FMT for pediatric rCDI.
    • To summarize the effectiveness of FMT in treating pediatric rCDI.

    Main Methods:

    • Literature review of studies on FMT for pediatric rCDI.
    • Analysis of clinical trial data and case reports.
    • Synthesis of current evidence regarding FMT efficacy and safety.

    Main Results:

    • FMT demonstrates significant effectiveness in resolving rCDI in children.
    • The procedure is generally well-tolerated with a favorable safety profile.
    • Specific indications and procedural nuances for pediatric FMT are highlighted.

    Conclusions:

    • Fecal microbiota transplantation is a viable and effective therapeutic option for pediatric recurrent CDI.
    • FMT offers a promising alternative to antibiotics by restoring gut microbial balance.
    • Further research may refine protocols and expand FMT applications in pediatric infectious diseases.

    More Related Videos

    Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model05:41

    Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

    Published on: April 6, 2022

    3.1K
    Murine Fecal Isolation and Microbiota Transplantation07:32

    Murine Fecal Isolation and Microbiota Transplantation

    Published on: May 26, 2023

    4.5K

    Related Concept Videos

    Drugs for Treatment of Diarrhea-Predominant IBS01:17

    Drugs for Treatment of Diarrhea-Predominant IBS

    Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
    Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
    350
    Inflammatory Bowel Disease V: Surgical Management01:21

    Inflammatory Bowel Disease V: Surgical Management

    Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
    Here are some common surgical interventions for IBD:
    245